Core Points - Tesla shareholders approved a significant pay package for CEO Elon Musk, marking a historic decision for the company [1] Group 1 - The approved pay package is controversial and has been a topic of discussion among investors and analysts [1] - The deal is structured to be worth up to a substantial amount, reflecting the company's growth and Musk's leadership [1]

IREN Limited (NASDAQ:IREN) shares were up after the company released its first-quarter earnings report after Thursday’s closing bell, beating estimates on the top and bottom lines.IREN reported quarterly earnings of $1.08 per share, which beat the consensus estimate of 14 cents per share. Quarterly revenue came in at $240.3 million, which beat the Street estimate of $235.5 million."IREN continues to execute with discipline, delivering record results this quarter and meaningful progress in our AI Cloud expan ...

Core Insights - Iovance Biotherapeutics reported a narrower loss of $0.25 per share for Q3 2025, compared to the Zacks Consensus Estimate of a loss of $0.29, and an improvement from a loss of $0.28 per share in the same quarter last year [1][7] - Quarterly revenues increased by 15% year over year to $67.5 million, although this figure fell short of the Zacks Consensus Estimate of $70.3 million [1][7] - The company experienced a significant gross margin increase to 43%, up from 5% in the previous quarter, attributed to cost optimization efforts [5][7] Revenue Breakdown - Amtagvi sales contributed approximately $57.5 million, reflecting a 37% year-over-year increase but missing the Zacks Consensus Estimate of $58 million [3] - Proleukin generated $10 million in sales, down 40% year over year, and also missed the Zacks Consensus Estimate of $15 million [3] Operating Costs - Research and development expenses rose to $75 million, a 12% increase from the previous year, driven by higher employee and clinical costs [4] - Selling, general, and administrative expenses decreased by 12% to nearly $36 million, primarily due to reduced stock compensation expenses [4] Financial Outlook - Iovance maintains its full-year product revenue guidance of $250 million to $300 million, anticipating significant growth in total product revenues for 2026 and beyond [9] - The company expects gross margins to improve through optimization of manufacturing capacity utilization over the next several years [9] Pipeline Developments - Regulatory applications for Amtagvi in melanoma are under review in Australia, Switzerland, and the UK, with potential approvals expected within two years [10] - Iovance is advancing its development programs for Amtagvi, including a phase III study in combination with Merck's Keytruda for advanced melanoma [11] - The company is also evaluating Amtagvi for other indications, including advanced non-squamous non-small cell lung cancer, with promising interim data reported [13][14]

GREENWICH, Conn., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Associated Capital Group, Inc. (“AC” or the “Company”) (OTCQX: ACGP), announced today several shareholder compensation initiatives. The Board of Directors (the “Board”) approved a 100% increase in the Company’s regular cash dividend. Beginning in 2026, the quarterly dividend rate will be set at $0.10 per share, compared to the current rate of $0.10 per share paid semi-annually. In addition, the Board declared a semi-annual dividend of $0.10 per share which ...

It's now time to discuss the latest we've seen from overall tech as it's been a pretty substantial move to the downside across the entire sector this week. So joining us now is Austin Lions, senior analyst of creative strategies. And so Austin, thank you so much for joining us on this Friday first and foremost, but excited to get your thoughts here because we've seen a lot of this riskoff sentiment sort of wayne and come really since Tuesday's session.So what do you make of this recent weakness. >> Great qu ...

Year to date revenue increased by $3.9 million to $43.5 million compared to $39.6 million for the same period of 2024. Boca Raton, FL, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Bright Mountain Media, Inc. (OTCQB: BMTM) (“Bright Mountain” or the “Company”), a global holding company with current investments in digital publishing, advertising technology, consumer insights, creative services, and media services, today announced its financial results for the third quarter and nine months ended September 30, 2025. Matt D ...

Peapack-Gladstone (PGC) came out with quarterly earnings of $0.54 per share, missing the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.43 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -8.47%. A quarter ago, it was expected that this bank holding company would post earnings of $0.61 per share when it actually produced earnings of $0.45, delivering a surprise of -26.23%.Over the last four quarter ...

Teleflex Incorporated (NYSE:TFX) reported better-than-expected earnings for the third quarter on Thursday.The company posted quarterly earnings of $3.67 per share which beat the analyst consensus estimate of $3.38 per share. The company reported quarterly sales of $913.021 million which beat the analyst consensus estimate of $892.777 million.Teleflex cut its FY2025 GAAP EPS guidance from $6.73-$7.13 to $(4.42)-$(4.22).“We executed well in the third quarter, delivering adjusted operating margin and earnings ...

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / Every company reaches a turning point when its technology stops being promise and starts becoming structure. SMX (NASDAQ:SMX) is there now. ...

Constellation Energy Corporation ( CEG ) has fallen hard since notching an all-time high above $410 just last month. Indeed, steam has been let out of the AI trade, and “Consto” as we used to call it on the trading floor (in a former life, I was an electricity/powerFreelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used in various formats including articles, blogs, emails, and social media for financial advisors and investment firms in a cost-efficient ...